Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | RDY | SUPN | ||
| Company | Cymabay Therapeutics | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 32.49 | 13.93 | 48.46 | ||
| High | 32.50 | 13.99 | 49.40 | ||
| Low | 32.48 | 13.93 | 48.18 | ||
| Latest | 32.48 | 13.93 | 48.75 | ||
| Change | +0.01 | +0.02 | +0.43 | ||
| % Change | +0.03% | +0.14% | +0.89% | ||
| Volume | 8,356,200 | 883,200 | 495,500 | ||
| 20-Day Average Volume | 3,390,805 | 1,106,765 | 643,085 | ||
| Previous Close | 32.47 | 13.91 | 48.32 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 13.98 | 46.00 | ||
| 20-Day Raw Stochastic | 94.12% | 51.75% | 87.84% | ||
| 20-Day Relative Strength | 78.00 | 48.60 | 56.13 | ||
| Weighted Alpha | +247.60 | -7.64 | +44.82 | ||
| Today's Opinion | 100% Buy | 100% Sell | 64% Buy | ||
| Previous Opinion | 100% Buy | 96% Sell | 64% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | +0.51% since 12/10/25 | +5.61% since 12/10/25 | ||
| Low | 32.44 on 03/15/24 | 13.90 on 12/16/25 | 45.88 on 12/11/25 | ||
| High | 32.50 on 03/21/24 | 14.16 on 12/12/25 | 49.40 on 12/17/25 | ||
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | -0.21% since 11/17/25 | +8.12% since 11/17/25 | ||
| Low | 32.15 on 02/22/24 | 13.64 on 11/24/25 | 44.05 on 11/18/25 | ||
| High | 32.50 on 03/21/24 | 14.20 on 12/05/25 | 49.40 on 12/17/25 | ||
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | -6.26% since 09/17/25 | +8.82% since 09/17/25 | ||
| Low | 22.11 on 01/26/24 | 13.14 on 10/29/25 | 43.11 on 11/05/25 | ||
| High | 32.50 on 03/21/24 | 14.97 on 09/19/25 | 57.65 on 10/30/25 | ||
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | -8.66% since 06/17/25 | +50.81% since 06/17/25 | ||
| Low | 12.32 on 10/13/23 | 13.14 on 10/29/25 | 30.83 on 06/25/25 | ||
| High | 32.50 on 03/21/24 | 15.71 on 06/25/25 | 57.65 on 10/30/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 11,613,988 | 2,770,621 | ||
| Shares Outstanding, K | 114,724 | 834,938 | 57,339 | ||
| Annual Sales | 31,070,000 | 3,811,000,000 | 661,820,000 | ||
| Annual Net Income | -105,370,000 | 663,000,000 | 73,870,000 | ||
| Last Quarter Sales | 60,000 | 1,012,590,000 | 192,100,000 | ||
| Last Quarter Net Income | -41,900,000 | 165,280,000 | -45,120,000 | ||
| 60-Month Beta | 0.32 | 0.39 | 0.71 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | 0.19 on 10/24/25 | 1.01 on 11/04/25 | ||
| Latest Earnings Date | 05/20/24 | 01/22/26 | 02/24/26 | ||
| Most Recent Dividend | N/A | 0.071 on 07/25/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 07/25/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.40 | 22.20 | ||